Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
EBIATLeasesLong-Term Debt IssuancesNon-Current ReceivablesOther Gross PP&E AdjustmentsReceivables RefundsShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Novartis Ag (NVSEF) Long-Term Debt Issuances (2017 - 2025)

Historic Long-Term Debt Issuances for Novartis Ag (NVSEF) over the last 4 years, with Q3 2025 value amounting to $135.0 million.

  • Novartis Ag's Long-Term Debt Issuances fell 9632.15% to $135.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.8 billion, marking a year-over-year increase of 4033.03%. This contributed to the annual value of $6.1 billion for FY2025, which is 73.25% down from last year.
  • As of Q3 2025, Novartis Ag's Long-Term Debt Issuances stood at $135.0 million, which was down 9632.15% from $2.5 billion recorded in Q4 2024.
  • Over the past 5 years, Novartis Ag's Long-Term Debt Issuances peaked at $3.7 billion during Q3 2024, and registered a low of $135.0 million during Q3 2025.